Doseology Sciences (XCNQ:MOOD) Total Stockholders Equity : C$1.14 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Doseology Sciences Total Stockholders Equity?

Doseology Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$1.14 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Doseology Sciences's Book Value per Share for the quarter that ended in Mar. 2024 was C$0.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Doseology Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Doseology Sciences Total Stockholders Equity Historical Data

The historical data trend for Doseology Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Total Stockholders Equity Chart

Doseology Sciences Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

1.07

2.58

3.00

1.30

Doseology Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial											2.39	1.30	1.23	1.17	1.14

Doseology Sciences (XCNQ:MOOD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Doseology Sciences's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1.138	-	0)	/	4.40052
	=	0.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Doseology Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1.138
	=	0.00

Doseology Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Doseology Sciences (XCNQ:MOOD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (XCNQ:MOOD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

DOSEF:USA

Address

116 - 5100 Anderson Way, Unit 197, Vernon, BC, CAN, V1T 0C4

Website

https://www.doseology.com

Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.

Doseology Sciences (XCNQ:MOOD) Headlines

No Headlines